Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bohm

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Cancer Research|February 15, 1989
A mechanism of inhibition of aflatoxin B1-DNA binding in the liver by phenobarbital pretreatment of ratsP D Lotlikar, H G Raj, L S Bohm, et al.
American Journal of Respiratory Cell and Molecular Biology|July 29, 1999
Cis-acting sequences from the rat cytochrome P450 2B1 gene confer pulmonary and phenobarbital-inducible expression in transgenic miceT Skarin, R Becher, A Bucht, et al.
British Journal of Cancer|May 1, 1994
The intramuscular administration of granulocyte colony-stimulating factor as an adjunct to chemotherapy in pretreated ovarian cancer patients: an Italian Trials in Medical Oncology (ITMO) Group pilot studyA Di Leo, E Bajetta, F Nolè, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
An I.T.M.O. group study on second-line treatment in advanced epithelial ovarian cancer: an attempt to identify clinical and biological factors determining prognosisA Di Leo, E Bajetta, L Biganzoli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Mitoxantrone and ifosfamide as second-line therapy of epithelial ovarian cancer. A pilot study by the I.T.M.O. GroupA Di Leo, E Bajetta, L Biganzoli, et al.
Tumori|December 31, 1994
An intensive treatment with mitoxantrone and ifosfamide in second-line therapy of epithelial ovarian cancerA D Leo, L Biganzoli, S Bohm, et al.
Frontiers in Cell and Developmental Biology|November 26, 2020
Low-Level Mouse DNA in Conditioned Medium Generates False Positive Cross-Species Contamination Results in Human Organoid CulturesMargaret S Bohm, Michael K Dame, Joseph Boyd, et al.
AJR. American Journal of Roentgenology|October 8, 1999
Stereotactic breast biopsy: en bloc excision of microcalcifications with a large-bore cannula deviceB Damascelli, L F Frigerio, G Patelli, et al.
Journal of Biomechanics|July 3, 2021
Stability recovery performance in adults over a wide age range: A multicentre reliability analysis using different lean-and-release test protocolsJ Werth, S Bohm, J Klenk, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 13, 2025
Murine Models of Obesity-Related Cancer RiskLukmon M Raji, Monowarul M Siddique, Margaret S Bohm, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Cancer Research|February 15, 1989
A mechanism of inhibition of aflatoxin B1-DNA binding in the liver by phenobarbital pretreatment of ratsP D Lotlikar, H G Raj, L S Bohm, et al.
American Journal of Respiratory Cell and Molecular Biology|July 29, 1999
Cis-acting sequences from the rat cytochrome P450 2B1 gene confer pulmonary and phenobarbital-inducible expression in transgenic miceT Skarin, R Becher, A Bucht, et al.
British Journal of Cancer|May 1, 1994
The intramuscular administration of granulocyte colony-stimulating factor as an adjunct to chemotherapy in pretreated ovarian cancer patients: an Italian Trials in Medical Oncology (ITMO) Group pilot studyA Di Leo, E Bajetta, F Nolè, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
An I.T.M.O. group study on second-line treatment in advanced epithelial ovarian cancer: an attempt to identify clinical and biological factors determining prognosisA Di Leo, E Bajetta, L Biganzoli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Mitoxantrone and ifosfamide as second-line therapy of epithelial ovarian cancer. A pilot study by the I.T.M.O. GroupA Di Leo, E Bajetta, L Biganzoli, et al.
Tumori|December 31, 1994
An intensive treatment with mitoxantrone and ifosfamide in second-line therapy of epithelial ovarian cancerA D Leo, L Biganzoli, S Bohm, et al.
Frontiers in Cell and Developmental Biology|November 26, 2020
Low-Level Mouse DNA in Conditioned Medium Generates False Positive Cross-Species Contamination Results in Human Organoid CulturesMargaret S Bohm, Michael K Dame, Joseph Boyd, et al.
AJR. American Journal of Roentgenology|October 8, 1999
Stereotactic breast biopsy: en bloc excision of microcalcifications with a large-bore cannula deviceB Damascelli, L F Frigerio, G Patelli, et al.
Journal of Biomechanics|July 3, 2021
Stability recovery performance in adults over a wide age range: A multicentre reliability analysis using different lean-and-release test protocolsJ Werth, S Bohm, J Klenk, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 13, 2025
Murine Models of Obesity-Related Cancer RiskLukmon M Raji, Monowarul M Siddique, Margaret S Bohm, et al.
Pageof 6